Huveaux PLC
06 December 2005
6 December 2005
HUVEAUX PLC
PRE-CLOSE TRADING UPDATE
Huveaux PLC, the publishing and media group, today provides the following
pre-close trading update:
Huveaux has doubled in size during 2005 through a combination of both organic
and acquisition-led growth and trading to date suggests a good out-turn for the
current financial year.
The Political Division has achieved underlying 11% organic sales growth in the
11 month period to 30 November. The controversial programme of reform by the UK
Government and the EU Parliament continues to drive increased revenue
opportunities across the Division's political publications and other media
channels.
The Learning Division has been significantly strengthened with the recent
acquisition of the e-learning business, Epic Group PLC, which was completed on
22 August. The integration of Epic is progressing well, with sales in line with
expectations and November orders particularly strong in the public sector. The
margins and profits from Epic during the last few months of the year have been
slightly higher than budgeted. The remainder of the Learning Division is trading
in line with expectations.
The Professional Division consists principally of the recently acquired JBB
Sante, a leading publisher of medical magazines in France. This acquisition was
completed on 5 October, a month later than planned. However, the integration of
JBB is also progressing well and trading is in line with expectations. JBB will
deliver a strong contribution to the Group's profits this year.
As previously indicated, the restructuring costs associated with the integration
of both Epic and JBB Sante into the Group will be taken as an exceptional item
and are expected to be within analysts' estimates.
Taken as a whole, the Board expects that Huveaux's sales and operating profit
for 2005, before exceptional items, will be in line with analysts' expectations.
The Company intends to announce its Preliminary Results for the financial year
ending 31 December 2005 in early March 2006.
For further information, please contact:
Huveaux PLC
John van Kuffeler, Executive Chairman 0207 245 0270
Finsbury
James Leviton 0207 251 3801
Don Hunter
Notes for Editors re Huveaux background:
Huveaux was formed in 2001 with the objective of building, over the next 10
years, a substantial publishing and media group through an appropriate balance
of acquisition-led and organic growth. Huveaux is focussed on the creation and
delivery of customer-critical information across both the public and private
sectors.
Since being admitted to AIM in December 2001, the Company has successfully
completed the acquisition of nine complementary businesses. It is the market
leader in political publishing and e-learning in the UK and one of the leading
medical publishers in France.
The Huveaux Group now consists of three Divisions: Political, Learning and
Professional which comprise a mix of magazines, websites, databases, reference
books, revision guides, manuals, videos, conferences, seminars and events in the
B2B sector. Huveaux has offices in London, Paris and Brussels as well as three
regional UK offices.
Huveaux was founded by John van Kuffeler, formerly Chief Executive and now
non-executive Chairman of Provident Financial plc.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.